Identification of M2 macrophage-related biomarkers for a predictive model of interstitial fibrosis and tubular atrophy after kidney transplantation by machine learning algorithms

利用机器学习算法鉴定M2巨噬细胞相关生物标志物,构建肾移植后间质纤维化和肾小管萎缩的预测模型

阅读:1

Abstract

BACKGROUND: Interstitial fibrosis and tubular atrophy (IFTA) represent significant histopathological manifestations contributing to long-term kidney allograft failure after transplantation. Identifying M2 macrophage (Mφ2)-related biomarkers could enhance early diagnosis and prognosis prediction, improving patient outcomes. This study aimed to explore Mφ2-related biomarkers for IFTA via bioinformatics and machine learning approaches. METHODS: RNA sequencing (RNA-seq) data from the GSE98320 dataset were analyzed to identify differentially expressed genes (DEGs). Immune cell profiling using the CIBERSORT algorithm and weighted gene co-expression network analysis (WGCNA) was performed to elucidate Mφ2-related biomarkers modules. Three machine learning algorithms were applied to identify hub genes. A nomogram model was developed and validated using multiple external datasets. Consensus clustering was employed to stratify patients into high-risk and low-risk groups based on hub gene expression. RESULTS: We obtained three hub genes (ALOX5, ARL4C, and MS4A6A) significantly associated with IFTA. The nomogram model demonstrated robust discriminatory power with an area under the curve (AUC) of 0.738 in the training cohort and 0.78-0.88 in external validation cohorts. Consensus clustering stratified patients into high-risk (cluster 1) and low-risk (cluster 2) groups, with elevated hub gene expression correlating with accelerated graft loss (P<0.001). Functional enrichment analysis revealed immune dysregulation and activation of fibrosis-related pathways in the high-risk group. CONCLUSIONS: Our findings uncovered novel Mφ2-related biomarkers for IFTA, offering diagnostic, prognostic, and therapeutic targets to improve kidney allograft outcomes. This study highlighted the potential of integrating bioinformatics and machine learning approaches to advance personalized medicine in kidney transplantation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。